A cluster randomized trial of Visitect CD4 Advanced Disease platform among outpatients with advanced HIV disease in Uganda

Abstract Introduction Despite significant progress in HIV care globally, a persistent 30–40% of people present with advanced HIV disease with ≤200 CD4 cells/µl. The Visitect CD4 Advanced Disease platform is a point‐of‐care CD4 test being implemented in resource‐limited settings. We sought to assess...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Elizabeth Nalintya, Elizabeth L. Schwartz, Patricia Nerima, Ann Fieberg, Sarah M. Najjuka, Ruth E. Ajilong, Tessa Adzemovic, Olive Namakula, Atukunda Mucunguzi, Kiiza Kandole Tadeo, Mark Oilor, Preethiya Sekar, Alice Lehman, Bruce Larson, Biyue Dai, David B. Meya, David R. Boulware, Radha Rajasingham, the ENCORE team
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wiley 2026-01-01
Schriftenreihe:	Journal of the International AIDS Society
Schlagworte:	advanced HIV disease opportunistic infections point‐of‐care CD4 count Visitect
Online-Zugang:	https://doi.org/10.1002/jia2.70075
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!